Axa Parenterals Ltd. is a WHO-GMP accredited company constructed in accordance with US FDA and EU guidelines to meet regulated market standards. We have a strong presence in African and CIC countries and are well-established in Southeast Asian nations. Operating within a comprehensive regulatory framework for prescription medications, our ultramodern plant is equipped with the latest technology. Spanning 145,000 sq. feet of land and 280,000 sq. feet of constructed area over two floors, we have emerged as a leader in all our business ventures and established a significant footprint with our customers.

---

---

Company Brands

PULMOST SF IPSAL-L PULMOST-T FURONASE LEVOMOL AXAFLU RS AXAMONT-L RIDPHLEGM SUPERCEF AXAZI LIZOGOLD MOZYFLEX PARACURE MANYLOX-G PULMOFOR B SALFLUTE PULMOFOR F BUDEXA PULMOTROP PULMOFRESH FLUNEB AXAMOL LEVODEXA ODIZOLE AXATIN AXAFLOX AXALINE 3% AXALYTE P FORTE AXATOL 20 AXADEX D5 AXADEX DNS AXARING RL DEXOGYL AXALYTE P AXALYTE M AXALYTE G AXAZOLE